Genotech Corporation (XKON:066830)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,190.00
-6.00 (-0.50%)
At close: Aug 21, 2025, 3:30 PM KST
-0.50%
Market Cap6.69B
Revenue (ttm)7.28B
Net Income (ttm)-1.32B
Shares Out5.60M
EPS (ttm)-280.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume637
Average Volume138
Open1,195.00
Previous Close1,196.00
Day's Range1,017.00 - 1,195.00
52-Week Range1,012.00 - 1,835.00
Beta0.21
RSI43.78
Earnings Daten/a

About Genotech

Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagn... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 066830
Full Company Profile

Financial Performance

In 2015, Genotech's revenue was 7.28 billion, an increase of 12.91% compared to the previous year's 6.45 billion. Losses were -1.32 billion, 250.7% more than in 2014.

Financial Statements

News

There is no news available yet.